1. Home
  2. KYTX vs LSE Comparison

KYTX vs LSE Comparison

Compare KYTX & LSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KYTX
  • LSE
  • Stock Information
  • Founded
  • KYTX 2018
  • LSE 2007
  • Country
  • KYTX United States
  • LSE China
  • Employees
  • KYTX N/A
  • LSE N/A
  • Industry
  • KYTX
  • LSE Metal Fabrications
  • Sector
  • KYTX
  • LSE Industrials
  • Exchange
  • KYTX NYSE
  • LSE Nasdaq
  • Market Cap
  • KYTX 92.1M
  • LSE 85.6M
  • IPO Year
  • KYTX 2024
  • LSE 2024
  • Fundamental
  • Price
  • KYTX $3.07
  • LSE $6.31
  • Analyst Decision
  • KYTX Strong Buy
  • LSE
  • Analyst Count
  • KYTX 5
  • LSE 0
  • Target Price
  • KYTX $19.00
  • LSE N/A
  • AVG Volume (30 Days)
  • KYTX 415.4K
  • LSE 1.3M
  • Earning Date
  • KYTX 08-11-2025
  • LSE 01-01-0001
  • Dividend Yield
  • KYTX N/A
  • LSE N/A
  • EPS Growth
  • KYTX N/A
  • LSE N/A
  • EPS
  • KYTX N/A
  • LSE 0.52
  • Revenue
  • KYTX N/A
  • LSE $69,073,374.00
  • Revenue This Year
  • KYTX N/A
  • LSE N/A
  • Revenue Next Year
  • KYTX N/A
  • LSE N/A
  • P/E Ratio
  • KYTX N/A
  • LSE $11.58
  • Revenue Growth
  • KYTX N/A
  • LSE N/A
  • 52 Week Low
  • KYTX $1.78
  • LSE $3.76
  • 52 Week High
  • KYTX $11.40
  • LSE $14.99
  • Technical
  • Relative Strength Index (RSI)
  • KYTX 55.92
  • LSE N/A
  • Support Level
  • KYTX $2.86
  • LSE N/A
  • Resistance Level
  • KYTX $2.82
  • LSE N/A
  • Average True Range (ATR)
  • KYTX 0.31
  • LSE 0.00
  • MACD
  • KYTX -0.03
  • LSE 0.00
  • Stochastic Oscillator
  • KYTX 40.94
  • LSE 0.00

About KYTX KYVERNA THERAPEUTICS INC

Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product, KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.

About LSE Leishen Energy Holding Co. Ltd. Ordinary Shares

Leishen Energy Holding Co Ltd is a provider of clean-energy equipment and integrated solutions to the oil and gas industry, with a commitment to providing customers with high-performance, safe, and cost-effective energy solutions. The company's business segments include clean-energy equipment; oil and gas engineering technical services; new energy production and operation; and digitalization and integration equipment. A majority of its revenue is generated from the clean-energy equipment segment which supplies various equipments, such as reciprocating compressor units, expansion units, wellhead heating systems, wellhead safety control systems, oil-water separation systems, natural gas online sampling systems, oil and gas skid-mounted equipment, and polymer flexible composite pipes.

Share on Social Networks: